Global Lab Automation in Drug Discovery Market - By Equipment , Type, Application, Mode of Automation, Geography, Forecasts, Trends - 2017 - 2022

  • ID: 4384894
  • Report
  • Region: Global
  • 101 pages
  • Mordor Intelligence
1 of 4
The Global Lab Automation in Drug Discovery market is valued at USD XX.XX billion in 2016 and is expected to reach a value of USD XX.XX billion by the end of 2022, growing at a projected CAGR of XX.XX% during the forecast period of 2017 - 2022. The emergence of robotics has transformed the typical workday for scientists around the world. With the advent of automation techniques, scientists are now able to set up, run, and analyze the results of experiments in a fraction of the time they needed in the past. In today's world, pulling maximum efficiency out of every department, including the R & D labs, is a major issue

Integrated robot systems are used to transport assay-microplates from station to station for sample and reagent addition, mixing, incubation, and finally readout or detection. These systems can usually prepare, incubate, and analyze many plates simultaneously, further speeding the data-collection process. High throughput screening is a major area in drug discovery where automation plays an important role.Automation of routine laboratory procedures, by the use of dedicated work stations and software to program instruments, allows associate scientists and technicians to think creatively about the implications of their experiments and to design effective follow-up projects or develop alternative approaches to their work instead of spending their days repeating tedious tasks.

Apart from reducing mundane tasks, the market for laboratory automation is also driven by the need for consistency in quality. Because the cost of an error is very high in a scientific paper or developing a drug, even fairly low error rates can have a profound impact on the conclusions you make downstream.

It is believed that taking out the human element helps in achieving more consistency. Great advances have been made in the molding of plastics that has reduced the volumes of reagents used and enabled handling of smaller liquid volumes easy. These advancements have worked in favor of the development of micro and nano-litre plates to fit in with the automated liquid handling equipment.

Validation and data quality play a major role in modern life science. Legal validation, patents, and clinical testing have become crucial issues. Automation enables a much higher reproducibility and better documentation of data. This allows the production of more data points with great ease. It also ensures the safety of personnel in the presence of infectious or potentially hazardous material.

Automation is used in a wide variety of life science applications ranging from proteomics to systems biology. Automation is a dominant feature in the diagnostics market followed by the discovery and research labs. In clinical diagnostics, where profits are based on the number of samples, high throughput is the core driving factor. Total automation is generally preferred in such labs and manufacturing setups. Research labs and academic institutions are generally opting for modular automation, wherein they reduce the human intervention in tedious and repetitive tasks.

North America is clearly the market leader with a total market share of 60%, followed by Europe. Asia and Latin America are emerging as there has been a considerable increase in outsourcing pharmaceutical manufacturing to these regions due to the availability of cheaper labor and resources.

This report analyzes the market across various geographies with the key trends in each region. It provides the market share and profiles of the top companies involved in lab automation. The report also provides insights on how the market will vary within the next five years.

DRIVERS

Advancement in plastic molding technology

Development of smaller automated machines

Need for higher reproducibility and effective management of the vast amounts of data generated

RESTRAINTS

Initial setup is expensive

Loss of flexibility in process

Interconnecting various platforms across the lab

Key Deliverables:

Market analysis for the global lab automation in drug discovery market, with region-specific assessments and competition analysis on a global and regional scale.

Market definition along with the identification of key drivers and restraints.

Identification of factors instrumental in changing the market scenario, rising prospective opportunities, and identification of key companies that can influence this market on a global and regional scale.

Extensively researched competitive landscape section with profiles of major companies along with their market share.

Identification and analysis of the macro and micro factors that affect the global lab automation in drug discovery market on both global and regional scale.

A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.

A wide-ranging knowledge and insights about the major players in this industry and the key strategies adopted by them to sustain and grow in the studied market.

Insights into the major countries/regions where this industry is growing and also identify the regions that are still untapped.
READ MORE
Note: Product cover images may vary from those shown
2 of 4
1. INTRODUCTION
1.1 Research Methodology
1.1.1 Definition of the Market
1.1.2 Report Description
1.1.3 Executive Summary
2. KEY FINDINGS OF THE STUDY
3. MARKET OVERVIEW
3.1 Market Segmentation
3.2 Overview
3.3 Industry Value-Chain Analysis
3.4 Industry Attractiveness - Porter's Five Forces Analysis
4. MARKET DYNAMICS
4.1 Introduction
4.2 Drivers
4.2.1 Advancement in Plastic Molding Technology
4.2.2 Development of Smaller Automated Machines
4.2.3 Need for Higher Reproducibility and Effective Management of the Vast Amounts of Data Generated
4.3 Constraints
4.3.1 Initial Setup is Expensive
4.3.2 Loss of Flexibility in Process
4.3.3 Interconnecting Various Platforms Across the Lab
5. Technology Overview
5.1 Technology Snapshot
5.2 Industry Applications
6. Different Equipment in Lab Automation
6.1 Automated Liquid Handlers
6.2 Automated Plate Handlers
6.3 Robotic Arms
6.4 Automated Storage & Retrieval Systems (ASRS)
7. MARKET ANALYSIS AND FORECAST
7.1 Global Market Segmented by Equipment
7.1.1 Automated Liquid Handlers
7.1.2 Automated Plate Handlers
7.1.3 Robotic Arms
7.1.4 Automated Storage & Retrieval Systems (ASRS)
7.2 Global Software Market
7.2.1 Laboratory Information Management System (LIMS)
7.2.2 Laboratory Information System (LIS)
7.2.3 Chromatography Data System (CDS)
7.2.4 Electronic Lab Notebook (ELN)
7.2.5 Scientific Data Management System (SDMS)
7.3 Global Analyzer Market
7.3.1 Biochemistry Analyzers
7.3.2 Immuno-based Analyzers
7.3.3 Hematology Analyzers
7.3.3.1 Cell Counters
7.3.3.2 Coulometers
7.4 Global Plate Readers Market - Segmented by Type
7.4.1 Absorbance
7.4.2 Fluorescence
7.4.3 Luminescence
7.4.4 Time-resolved Fluorescence
7.4.5 Fluorescence Polarization
7.4.6 Light Scattering
7.5 Global Market - Segmented By Region
7.5.1 North America
7.5.1.1 USA
7.5.1.2 Canada
7.5.1.3 Others
7.5.2 Europe
7.5.2.1 Germany
7.5.2.2 United Kingdom
7.5.2.3 Spain
7.5.2.4 Others
7.5.3 APAC
7.5.3.1 Japan
7.5.3.2 China
7.5.3.3 South Korea
7.5.3.4 Others
7.5.4 ROW
8. Competitive Landscape
8.1 Mergers & Acquisitions
8.2 Joint Ventures
8.3 New Product Launches
8.4 Five Biggest Companies by Revenue
8.5 Two Most Active Companies in the Past Three Years
9. Company Profiles
9.1 Thermo Scientific
9.1.1 Overview
9.1.2 Major Products and Services
9.1.3 Financials
9.1.4 Recent Developments
9.2 Danaher
9.2.1 Overview
9.2.2 Major Products and Services
9.2.3 Financials
9.2.4 Recent Developments
9.3 Hudson Robotics
9.3.1 Overview
9.3.2 Major Products and Services
9.3.3 Financials
9.3.4 Recent Developments
9.4 Beckton Dickinson
9.4.1 Overview
9.4.2 Major Products and Services
9.4.3 Financials
9.4.4 Recent Developments
9.5 Synchron Lab
9.5.1 Overview
9.5.2 Major Products and Services
9.5.3 Financials
9.5.4 Recent Developments
9.6 Agilent Technologies
9.6.1 Overview
9.6.2 Major Products and Services
9.6.3 Financials
9.6.4 Recent Developments
9.7 Siemens Healthcare
9.7.1 Overview
9.7.2 Major Products and Services
9.7.3 Financials
9.7.4 Recent Developments
9.8 Tecan Group Ltd
9.8.1 Overview
9.8.2 Major Products and Services
9.8.3 Financials
9.8.4 Recent Developments
9.9 PerkinElmer
9.9.1 Overview
9.9.2 Major Products and Services
9.9.3 Financials
9.9.4 Recent Developments
9.10 Honeywell
9.10.1 Overview
9.10.2 Major Products and Services
9.10.3 Financials
9.10.4 Recent Developments
9.11 BioRad
9.11.1 Overview
9.11.2 Major Products and Services
9.11.3 Financials
9.11.4 Recent Developments
9.12 Roche Holding Ag
9.12.1 Overview
9.12.2 Major Products and Services
9.12.3 Financials
9.12.4 Recent Developments
9.13 Eppendorf Ag
9.13.1 Overview
9.13.2 Major Products and Services
9.13.3 Financials
9.13.4 Recent Developments
9.14 Shimadzu
9.14.1 Overview
9.14.2 Major Products and Services
9.14.3 Financials
9.14.4 Recent Developments
9.15 Aurora Biomed
9.15.1 Overview
9.15.2 Major Products and Services
9.15.3 Financials
9.15.4 Recent Developments
10. Appendix
10.1 Abbreviations
10.2 Sources
10.3 Bibliography
10.4 Disclaimer
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
Note: Product cover images may vary from those shown
Adroll
adroll